MATERNAL VITAMIN-A SUPPLEMENTATION IN RELATION TO SELECTED BIRTH-DEFECTS

High doses of vitamin A cause birth defects in animals. Concern over vitamin A teratogenicity in humans has been prompted by reports of teratogenic effects of the vitamin A analogue, isotretinoin. The pattern of defects observed among isotretinoin‐ and vitamin A‐exposed infants and animals suggests a possible mechanism involving cranial neural crest cell activity. Data from a case‐control study were used to assess maternal use of vitamin A supplements alone and vitamin A‐containing multivitamin supplements in relation to the occurrence of certain birth defects involving structures derived, at least in part, from cranial neural crest cells. Cases were 2,658 infants with such defects (primarily craniofacial and cardiac malformations). Controls were 2,609 infants with other malformations. Vitamin A supplementation was defined as daily use for at least 7 days of retinol alone or with vitamin D, or of fish oils. Information on vitamin A dose and nutrition was not available. The mothers of six controls used vitamin A supplements in each of the first three lunar months of pregnancy in comparison to the mothers of 15, 14, and 10 cases in lunar months 1, 2, and 3, respectively. Relative risk estimates and 95% confidence intervals were 2.5(1.0–6.2) for lunar month 1, 2.3(0.9–5.8) for lunar month 2, and 1.6(0.6–4.5) for lunar month 3. These findings should be considered tentative because no dose information was available, small numbers of cases and controls were exposed to vitamin A supplements, and relative risk estimates were not statistically significant. Separate analyses of the more common intake of multivitamins which contain vitamin A, including “prenatal” vitamins, found relative risks of these defects for daily use approximated unity and 95% confidence intervals excluded even small increases in risk. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company